| 1 |
33671323 | Pharmacokinetics of the CYP3A4 and CYP2B6 Inducer Carbamazepine and Its Drug-Drug Interaction Potential: A Physiologically Based Pharmacokinetic Modeling Approach. | 2021 Feb 17 |
3 |
| 2 |
26711482 | Evaluation of cytochrome P450 inductions by anti-epileptic drug oxcarbazepine, 10-hydroxyoxcarbazepine, and carbamazepine using human hepatocytes and HepaRG cells. | 2016 Sep |
2 |
| 3 |
26516577 | Applicability of second-generation upcyte® human hepatocytes for use in CYP inhibition and induction studies. | 2015 Oct |
1 |
| 4 |
17559344 | Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro. | 2007 Jun |
1 |
| 5 |
12386121 | Pathways of carbamazepine bioactivation in vitro I. Characterization of human cytochromes P450 responsible for the formation of 2- and 3-hydroxylated metabolites. | 2002 Nov |
1 |
| 6 |
9630846 | Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin. | 1998 May 1 |
5 |
| 7 |
8503477 | Recent pharmacologic advances in antidepressant therapy for the elderly. | 1993 May 24 |
1 |